LEVERAGING THE SCCM DISCOVERY VIRUS COVID-19 REGISTRY TO EVALUATE DRUG REPURPOSING RESEARCH DATASET

被引：0
|
作者：
Heavner, Smith [1 ]
Howard, Kerry [1 ]
Pauley, Mike [1 ]
Dasher, Pam [1 ]
Sivaraj, Laksika [2 ]
Podichetty, Jagdeep [1 ]
Kumar, Vishakha [3 ]
Schito, Marco [1 ]
Kashyap, Rahul [4 ]
机构：
[1] Crit Path Inst, Tucson, AZ USA
[2] Prisma Hlth, Columbia, SC USA
[3] Soc Crit Care Med, Mt Prospect, IL USA
[4] Mayo Fdn, Rochester, MN USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1126
引用
收藏
页码：561 / 561
页数：1
相关论文
共 50 条
  • [41] Drug Discovery Targeting COVID-19
    Spicer, Timothy P.
    SLAS DISCOVERY, 2020, 25 (10) : 1095 - 1096
  • [42] A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics
    Wattanakul, Thanaporn
    Chotsiri, Palang
    Scandale, Ivan
    Hoglund, Richard M.
    Tarning, Joel
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (08) : 945 - 958
  • [43] ASSOCIATION BETWEEN GI SYMPTOMS AND COVID-19: RESULTS FROM THE DISCOVERY VIRUS REGISTRY
    Sharma, Mayank
    Tekin, Aysun
    Bansal, Vikas
    Bogojevic, Marija
    Singh, Romil
    LeMahieu, Allison
    La Nou, Abigail
    Hanson, Andrew
    Schulte, Phillip
    Deo, Neha
    Qamar, Shahraz
    Zec, Simon
    Kumar, Vishakha
    Walkey, Allan
    Acosta, Andres
    Gajic, Ognjen
    Kashyap, Rahul
    Pablo, Juan
    Garces, Domecq
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 49 - 49
  • [44] Cutaneous manifestations of hospitalized COVID-19 patients in the VIRUS COVID-19 registry
    Deo, Neha
    Tekin, Aysun
    Bansal, Vikas
    Koritala, Thoyaja
    Mullen, Barbara
    Armaignac, Donna L.
    Chiotos, Kathleen
    Bjornstad, Erica C.
    Gharpure, Varsha P.
    Bogojevic, Marija
    Qamar, Shahraz
    Singh, Romil
    Sharma, Mayank
    Gajic, Ognjen
    Kumar, Vishakha
    Walkey, Allan
    Kashyap, Rahul
    Domecq, Juan P.
    Alavi, Afsaneh
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (05) : 623 - 625
  • [45] Discovery of potent Covid-19 main protease inhibitors using integrated drug-repurposing strategy
    Kumar, Muthu T.
    Rohini, K.
    James, Nivya
    Shanthi, V
    Ramanathan, K.
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2021, 68 (04) : 712 - 725
  • [46] THE IMPACT OF STEROIDS ON OUTCOMES OF CHILDREN ADMITTED TO THE HOSPITAL WITH NON MISC COVID19: AN ANALYSIS FROM THE SCCM DISCOVERY NETWORK VIRUS REGISTRY
    Nadiger, M.
    Harthan, A.
    Mcgarvey, J. S.
    Lombardo, M. Y.
    Gharpure, V. P.
    Perkins, N.
    Chiotos, K.
    Kashyap, R.
    Kumar, V. K.
    Walkey, A. J.
    Tripathi, S.
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (11)
  • [47] Repurposing the drug, ivermectin, in COVID-19: toxicological points of view
    Shirazi, Farshad M.
    Mirzaei, Roya
    Nakhaee, Samaneh
    Nejatian, Amir
    Ghafari, Shokouh
    Mehrpour, Omid
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [48] Combating COVID-19: The role of drug repurposing and medicinal plants
    Khan, Shah A.
    Al-Balushi, K.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (04) : 495 - 503
  • [49] Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (10): : 928 - 928
  • [50] Letter to the Editor: Repurposing of an Antisepsis Drug in COVID-19 Patients
    Kumar, Ashutosh
    Pareek, Vikas
    Kant, Kamla
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2021, 19 (07) : 407 - +
12345